
Michael J. Morris, MD
Medical Oncologist
Titles
Prostate Cancer Section Head, GU Oncology
Clinical Expertise
Prostate Cancer; New Investigational Agents
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Morris accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 646-422-4469 Office Phone
- Follow Dr. Morris on Twitter
- Speaks English

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, Mount Sinai School of Medicine
Residencies
Medicine - Columbia Presbyterian Medical Center
Fellowships
Oncology/Hematology - Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College
Board Certifications
Medical Oncology
I am a board-certified medical oncologist who specializes in treating men with prostate cancer, particularly those who have metastatic disease (disease that has spread to distant organs) or who are at high risk of developing metastatic disease. I am the Prostate Cancer Section Head, which means I lead a group of experts who are dedicated to researching and treating this disease.
Read more
Much of my research focuses on drugs that can deliver radioactive molecules targeted specifically to prostate cancer cells or to the distant areas where the cancer spreads. These drugs can be used alone or in combination with other anti-cancer strategies. This research represents a team effort between medical oncologists, nuclear medicine doctors, and radiologists to bring these novel and exciting drugs to the people with prostate cancer who need them.
I am also interested in developing new ways to image prostate cancer using unique, prostate-cancer-specific PET scans and other new imaging methods. This type of imaging not only provides insight into where the prostate cancer is located but informs us about its biology as well. Treatments can then be more precisely and personally tailored to an individual’s disease.
One of my priorities is increasing patient access to clinical trials. I am one of the leaders of the Prostate Cancer Clinical Trials Consortium. This initiative is designed to increase patient access to clinical trials across the country. I also chair the Genitourinary Committee of the National Cancer Institute’s cooperative group Alliance for Clinical Trials in Oncology, which facilitates testing new drugs nationwide. I have been very involved with the American Society of Clinical Oncology, taking various roles centering around prostate cancer and other genitourinary diseases.
Awards and Honors
- Castle Connolly: America's Top Doctors (2023)
- Castle Connolly: New York Magazine Top Doctors (2013
- 2015-2020)
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Morris
- A Phase I Study of JNJ-69086420 for Advanced Prostate Cancer
- [18F]-Deoxy-D-Glucose (FDG) and [18F] Dihydro-Testosterone PET Imaging in Patients with Progressive Prostate Cancer
- Clinical Trials Co-Investigated by Dr. Morris
- A Phase I Study of AMG 509 in Men with Advanced Prostate Cancer
- A Phase I Study of ORIC-944 to Treat Metastatic Prostate Cancer
Read more
- A Phase II Study Assessing Ceralasertib to Treat Advanced Prostate Cancer and Other Solid Tumors with Certain Molecular Changes
- A Phase II Study Assessing the Interruption of Hormonal Medications in Patients Responding Well to Therapy for Metastatic Prostate Cancer
- A Phase II Study of Stereotactic Body Radiation Therapy and Radium Dichloride to Treat Prostate Cancer that Has Spread to the Bones
- A Phase III Study Comparing 177Lu-PSMA-617 plus Standard of Care versus Standard of Care Alone to Treat Metastatic Hormone-Sensitive Prostate Cancer

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Morris’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Michael J. Morris discloses the following relationships and financial interests:
-
Advanced Accelerator Applications USA
Provision of Services (uncompensated) -
Amgen
Provision of Services -
AstraZeneca
Provision of Services -
Bayer
Provision of Services (uncompensated) -
Convergent Therapeutics, Inc.
Provision of Services -
Daiichi Sankyo
Provision of Services -
Digital Science Press
Provision of Services -
Doximity, Inc.
Ownership / Equity Interests
-
Exelixis
Provision of Services -
ITM Isotopen Technologien München AG
Provision of Services -
Janssen Research & Development, LLC
Provision of Services (uncompensated) -
Lantheus Medical Imaging, Inc.
Provision of Services -
Novartis
Provision of Services (uncompensated) -
Oric Pharmaceuticals
Provision of Services (uncompensated) -
Pfizer, Inc.
Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].